FDA New Approvals of COVID-19 Vaccines

Approved COVID-19 Vaccines
As of late August 2025, the U.S. Food and Drug Administration (FDA) has approved updated versions of the COVID-19 vaccines from Pfizer, Moderna and Novavax.  These updated shots are intended to better protect against currently circulating variants.

The 2024–2025 formulations of the following vaccines are approved for certain groups:

Please click here to subscribe or here to log in.